Does anybody know what percentage of BRM is owned by the directors and large institutions?It worries me that, if the total is close to 30%, they can easily supprt Wah Nam's bid and get this t/o through.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling